Five people in the East of England have become the first to benefit from a pioneering treatment for heart valve disease at ...

Transcatheter aortic valve implantation (TAVI) is now an established treatment option for elderly patients with severe ...

RATES of permanent pacemaker implantation (PPI) exceed 20% in patients with aortic regurgitation (AR). A new retrospective ...

Dapagliflozin reduced the risk of all-cause mortality or worsening heart failure by 28% in patients with aortic stenosis ...

Transcatheter Aortic Valve Implantation (TAVI) procedure turned out to be a boon for a 78-year-old woman, who was diagnosed with a severe aortic stenosis, a serious heart condition.

A nationwide analysis of Spanish data reveals an increase in the risk for permanent pacemaker implantation following ...

Transcatheter aortic valve implantation (TAVI) has become the preferred treatment for high-risk patients with severe aortic stenosis. However, individuals with pre-existing coronary stents protruding ...

The FDA has granted 510(k) clearance to the TaviPilot AI software developed by Caranx Medical, according to company officials ...

In this randomized trial, the use of cerebral embolic protection (CEP) did not decrease the 72-hour incidence of stroke in ...

Patients received a new treatment for heart valve disease, which did not require riskier open-heart surgery or travel to London. Five people from Cambridgeshire, Essex, Hertfordshire, Peterborough and ...

Depending on procedure, the transfemoral, segment dominated the market in 2020, and this trend is expected to continue during ...

Global Percutaneous Aortic Valve Implantation Market Anticipated to Garner $13,454.6 Million in Revenue, Rising at a CAGR of 13.9% over the Estimated Timeframe, 2021 to 2028 [160-Pages ...